ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
University of Wisconsin, Madison
University of Wisconsin, Madison
University of California, Irvine
University of Michigan Rogel Cancer Center
Universitaire Ziekenhuizen KU Leuven
Shanghai Zhongshan Hospital
M.D. Anderson Cancer Center
University of Pittsburgh
NYU Langone Health
Shanghai Zhongshan Hospital
Herlev Hospital
Maastricht University Medical Center
University of Zurich
University Hospital Augsburg
Case Comprehensive Cancer Center
Duke University
Jules Bordet Institute
Peking University Cancer Hospital & Institute
University of Pittsburgh
M.D. Anderson Cancer Center
University Hospital, Grenoble
Kaiser Permanente
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
Centre Hospitalier Régional Metz-Thionville
West Virginia University
Indiana University
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Helsinki University Central Hospital
Centre Georges Francois Leclerc
National University Hospital, Singapore
Henry Ford Health System
Nantes University Hospital
UNICANCER
Universitaire Ziekenhuizen KU Leuven
McMaster University
Ohio State University Comprehensive Cancer Center
The Christie NHS Foundation Trust
University Hospital, Lille
Petrov, Andrey
Centre Hospitalier Universitaire de Nīmes
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Xijing Hospital
SRH Wald-Klinikum Gera GmbH
Fondazione Italiana Linfomi - ETS
Region Skane
Samsung Medical Center
Maria Sklodowska-Curie National Research Institute of Oncology
Northwestern University
IRCCS Ospedale San Raffaele